Login
$BNR
$11.87 +$0.72 (6.46%) Close

Insider Transactions

What Burning Rock Biotech Limited's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 8
Sells 0 0
Total trades 0 8

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

Common stock only — 8 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Han Yusheng Director Jun 26 Open-market buy · P +24,900 $8.00 +$199K 18,404,086
Han Yusheng Director Jun 24 Open-market buy · P +250,000 $8.00 +$2M 18,379,186
Han Yusheng Director Jun 23 Open-market buy · P +5,990 $7.50 +$44.9K 18,129,186
Han Yusheng Director Jun 22 Open-market buy · P +104,650 $7.45 +$780K 18,123,196
Han Yusheng Director Jun 16 Open-market buy · P +111,110 $9.00 +$1M 18,018,546
Han Yusheng Director Jun 12 Open-market buy · P +210,000 $9.25 +$1.94M 17,907,436
Han Yusheng Director Jun 11 Open-market buy · P +24,760 $8.74 +$216K 17,697,436
Han Yusheng Director Mar 31 Open-market buy · P +314,870 $17.36 +$5.47M 17,672,676

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support